SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Wallentin Lars C. 1943 )
 

Sökning: WFRF:(Wallentin Lars C. 1943 ) > (2015-2019) > (2018) > Lp-PLA(2), scavenge...

  • Manichaikul, AniUniv Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA;Univ Virginia, Dept Publ Hlth Sci, Biostat Sect, Charlottesville, VA USA (författare)

Lp-PLA(2), scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease

  • Artikel/kapitelEngelska2018

Förlag, utgivningsår, omfång ...

  • 2018-10-05
  • PUBLIC LIBRARY SCIENCE,2018
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-368449
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-368449URI
  • https://doi.org/10.1371/journal.pone.0204352DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background We previously reported association of SCARB1 SNP rs10846744 with common carotid IMT (cIMT) and cardiovascular disease (CVD) events. Since rs10846744 has been reported in association with Lp-PLA(2) mass and activity, we hypothesized that inflammatory pathways might mediate the association of rs10846744 with atherosclerosis. Methods We first examined association of rs10846744 in CVD in multiple large-scale consortium-based genome-wide association studies. We further examined 27 parameters of interest, including Lp-PLA(2) mass and activity, inflammatory markers, and plasma phospholipid fatty acids, and fatty acid ratios in participants from the Multi-Ethnic Study of Atherosclerosis (MESA), as potential mediators in the pathway linking rs10846744 with cIMT and incident CVD. Finally, we examined the association of rs10846744 with Lp-PLA(2) activity, cardiovascular outcomes, and interaction with the Lp-PLA(2) inhibitor, darapladib, in the Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy (STABILITY) and Stabilization of Plaque using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) studies. Results SCARB1 rs10846744 was associated with coronary artery disease events in CARDIo-GRAMplusC4D (odds ratio 1.05; 95% CI [1.02, 1.07]; P= 1.4x10(-4)). In combined analysis across race/ethnic groups in MESA, rs10846744 was associated with Lp-PLA(2 )mass (P= 0.04) and activity (P = 0.001), homocysteine (P = 0.03), LDL particle number (P = 0.01), docosahexaenoic acid [DHA] (P = 0.01), docosapentaenoic acid [DPA] (P = 0.04), DPA/eicosapentaenoic acid [EPA] ratio (P= 0.002), and DHA/EPA ratio (P= 0.008). Lp-PLA(2) activity was identified as a mediator of rs10846744 with cIMT in a basic model (P = 8x10(-5)), but not after adjustment for CVD risk factors. There was no interaction or modifier effect of the Lp-PLA(2) inhibitor darapladib assignment on the relationship between rs10846744 and major CVD events in either STABILITY or SOLID-TIMI 52. Summary SCARB1 rs10846744 is significantly associated with Lp-PLA(2) activity, atherosclerosis, and CVD events, but Lp-PLA(2) activity is not a mediator in the association of rs10846744 with cIMT in MESA.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Wang, Xin-QunUniv Virginia, Dept Publ Hlth Sci, Biostat Sect, Charlottesville, VA USA (författare)
  • Li, LiPAREXEL Int, Genom Med, Durham, NC USA (författare)
  • Erdmann, JeanetteUniv Lubeck, Inst Integrat & Expt Genom, Lubeck, Germany;DZHK German Res Ctr Cardiovasc Res, Partner Site Hamburg, Lubeck, Germany (författare)
  • Lettre, GuillaumeMontreal Heart Inst, Montreal, PQ, Canada;Univ Montreal, Montreal, PQ, Canada (författare)
  • Bis, Joshua C.Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA;Univ Washington, Dept Med, Seattle, WA USA (författare)
  • Waterworth, DawnGlaxoSmithKline, Genet, King Of Prussia, PA USA (författare)
  • Cushman, MaryUniv Vermont, Dept Med, Burlington, VT USA;Univ Vermont, Dept Pathol & Lab Med, Burlington, VT USA (författare)
  • Jenny, Nancy S.Univ Vermont, Dept Pathol & Lab Med, Burlington, VT USA (författare)
  • Post, Wendy S.Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA;Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA (författare)
  • Palmas, WalterColumbia Univ, Coll Phys & Surg, Dept Med, Div Gen Med, New York, NY USA (författare)
  • Tsai, Michael Y.Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA (författare)
  • Wallentin, Lars,1943-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi(Swepub:uu)larswall (författare)
  • White, HarveyAuckland City Hosp Green Lane Cardiovasc Sci, Auckland, New Zealand (författare)
  • Schunkert, HeribertDZHK German Res Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany;Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany (författare)
  • O'Donnell, Christopher J.Boston Vet Adm Healthcare, Cardiol Sect, Boston, MA USA;NHLBI, Framingham, MA USA;Boston Univ Framingham Heart Study, Framingham, MA USA (författare)
  • Herrington, David M.Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA (författare)
  • Rich, Stephen S.Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA;Univ Virginia, Dept Publ Hlth Sci, Biostat Sect, Charlottesville, VA USA (författare)
  • O'Donoghue, Michelle L.Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA (författare)
  • Rodriguez, AnnabelleUniv Connecticut Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT 06030 USA (författare)
  • Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA;Univ Virginia, Dept Publ Hlth Sci, Biostat Sect, Charlottesville, VA USAUniv Virginia, Dept Publ Hlth Sci, Biostat Sect, Charlottesville, VA USA (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:PLOS ONE: PUBLIC LIBRARY SCIENCE13:101932-6203

Internetlänk

Hitta via bibliotek

  • PLOS ONE (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy